Please use this identifier to cite or link to this item:
http://repositorio.ufla.br/jspui/handle/1/39870| metadata.artigo.dc.title: | Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs |
| metadata.artigo.dc.creator: | Georgiev, Tsvetoslav |
| metadata.artigo.dc.subject: | COVID 19 COVID 19 - Drugs Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |
| metadata.artigo.dc.publisher: | Springer |
| metadata.artigo.dc.date.issued: | 2020 |
| metadata.artigo.dc.identifier.citation: | GEORGIEV, T. Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs. Rheumatology International, [S.l.], v. 40, p. 825-826, 2020. |
| metadata.artigo.dc.description.resumo: | Indisponível. |
| metadata.artigo.dc.description.abstract: | Indisponível. |
| metadata.artigo.dc.identifier.uri: | https://link.springer.com/article/10.1007/s00296-020-04570-z http://repositorio.ufla.br/jspui/handle/1/39870 |
| metadata.artigo.dc.language: | en_US |
| Appears in Collections: | FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19) |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.